Yuchun Lee - Jan 17, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jan 17, 2023
Transactions value $
-$1,065,653
Form type
4
Date filed
1/19/2023, 03:07 PM
Previous filing
May 3, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $289K +4K +213.33% $72.14 5.88K Jan 17, 2023 Direct
transaction VRTX Common Stock Sale -$1.25M -4K -68.09% $312.03 1.88K Jan 17, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Options Exercise $31.9K +442 +23.57% $72.14 2.32K Jan 18, 2023 Direct
transaction VRTX Common Stock Sale -$138K -442 -19.08% $312.17 1.88K Jan 18, 2023 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -4K -20% $0.00 16K Jan 17, 2023 Common Stock 4K $72.14 Direct F5
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -442 -2.76% $0.00 15.6K Jan 18, 2023 Common Stock 442 $72.14 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $312.03 (range $312.00 to $312.14).
F4 Open market sales reported on this line occurred at a weighted average price of $312.17 (range $312.00 to $312.53).
F5 Fully vested.